Clinical performance of a machine learning-based model for detecting lymph node metastasis in papillary thyroid carcinoma: A multicenter study.

Journal: International journal of surgery (London, England)
Published Date:

Abstract

Papillary thyroid carcinoma (PTC) is a common endocrine malignancy with a generally favorable prognosis, but lymph node metastasis (LNM) complicates treatment and increases recurrence risk. Current preoperative methods like neck ultrasound often miss LNM, leading to unnecessary surgeries. This study developed a non-invasive, artificial intelligence (AI)-driven predictive model for LNM using gene expression data from 157 PTC patients and validated it with qRT-PCR across 807 participants from multiple centers. The model focused on three key genes - RPS4Y1, PKHD1L1, and CRABP1 - chosen for their predictive strength. A random forest algorithm achieved high accuracy, with an AUROC of 0.992 in training and 0.911-0.953 in external validation. RPS4Y1 emerged as a standout predictor, showing the strongest distinction between metastatic and non-metastatic cases. The study also identified immune-related pathways, such as TGF-β signaling and cancer-associated fibroblast activation, as critical in metastasis. This gene expression-based model offers a non-invasive, cost-effective solution for predicting LNM, providing valuable insights to guide surgical decisions and reduce unnecessary procedures, ultimately improving patient outcomes.

Authors

  • Wei Liu
    Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, United States.
  • Jiaojiao Zheng
    Department of General Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai, China.
  • Liang Han
    Department of Computer Science, Missouri University of Science and Technology, Rolla, MO, 65401 United States. Electronic address: lh248@mst.edu.
  • Weifeng Qu
    Department of General Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai, China.
  • Qiao Wu
    Emergency Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Zhou Yuan
    University of Pittsburgh, Pittsburgh, PA.
  • Gaolei Jia
    Department of Thyroid surgery, Xuzhou Central Hospital, Xuzhou, China.
  • Xiaolong Wang
    Cardiovascular Department, Shuguang Hospital Affiliated to Shanghai University of TCM Shanghai, China.
  • Linxiong Ye
    Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
  • Jiaqi Zhang
  • Shisheng Zhang
  • Xuanye Cao
    Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai, China.
  • Ying Liu
    The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
  • Zhilong Ai
    Department of General Surgery (Thyroid & Breast), Zhongshan Hospital, Fudan University, Shanghai, China.